MLAB vs PATH
Mesa Laboratories Inc (MLAB) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Mesa Laboratories Inc (MLAB) is a scientific & technical instruments company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported MLAB revenue for 2025-03-31 was $241.0M. Net income was -$2.0M. Revenue was up 11.5% from 2024-03-31 to 2025-03-31. MLAB currently screens at market cap $538.3M and trailing P/E 80.5.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
MLAB currently screens at market cap $538.3M and trailing P/E 80.5. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the MLAB and PATH stock pages for the full models.
Not investment advice.